Commonwealth Equity Services
COCP icon

Commonwealth Equity Services’s Cocrystal Pharma COCP Stock Holding History

Commonwealth Equity Services’s Portfolio COCP Stock Details COCP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-2,083
Closed -$7K – 3725
2022
Q3 		$7K Sell
2,083
-129
-6% -$604 ﹤0.01% 3632
2022
Q2 		$10K Hold
2,212
– – ﹤0.01% 3621
2022
Q1 		$14K Hold
2,212
– – ﹤0.01% 3674
2021
Q4 		$17K Buy
2,212
+833
+60% +$8.53K ﹤0.01% 3612
2021
Q3 		$17K Buy
1,379
+4
+0.3% +$53 ﹤0.01% 3551
2021
Q2 		$20K Buy
1,375
+417
+44% +$6.34K ﹤0.01% 3498
2021
Q1 		$15K Sell
958
-417
-30% -$8.47K ﹤0.01% 3385
2020
Q4 		$22K Buy
+1,375
New +$19.1K ﹤0.01% 3172
2020
Q2 		– Sell
-833
Closed -$7K – 2956
2020
Q1 		$7K Buy
+833
New +$7.84K ﹤0.01% 2797

Other funds holding COCP

SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PA
Parallel Advisors San Francisco, California $5.56B AUM 17.89% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Commonwealth Equity Services's COCP Position: Q4 2022 in Review

Commonwealth Equity Services sold out of Cocrystal Pharma (COCP) in Q4 2022, closing a stake of 2,083 shares — an estimated $7K sold.

Commonwealth Equity Services first reported a position in COCP in Q1 2020 and held it in 9 quarters. The position peaked at $22K in Q4 2020. 21 funds tracked by Wall St. Rank hold COCP as of Q4 2022.

  • Commonwealth Equity Services reported no remaining Cocrystal Pharma position as of Q4 2022 after selling out during the quarter.
  • Commonwealth Equity Services sold 2,083 Cocrystal Pharma shares in Q4 2022, an estimated $7K.
  • Commonwealth Equity Services first reported a position in Cocrystal Pharma in Q1 2020 and held it in 9 quarters.
  • Commonwealth Equity Services's Cocrystal Pharma position peaked at $22K in Q4 2020.
  • 21 funds tracked by Wall St. Rank held Cocrystal Pharma as of Q4 2022.

Based on Commonwealth Equity Services's 13F filing for Q4 2022, filed 7 Feb 2023.